Bulletin of Alexandria Faculty of Medicine. 1993; 29 (5): 1209-15
in English
| IMEMR
| ID: emr-27532
ABSTRACT
A comparative clinical trial of two once-a-month injectable contraceptives [cyclofem and mesigyna] was carried out in Shatby University Hospital. A total of 297 women [150 for cyclofem and 147 for mesigyna] were recruited in the study and were followed for a period of 12 months. The two groups of women were comparable in all aspects, 86.9% of women continued until the end of 12 months. The contraceptive efficacy for both regimen was 100%. More than 90% of women in both groups did not have any complaints during the 12 follow-up visits. No significant differences was found between the two groups as regards continuation and discontinuation rates, menstrual pattern, blood pressure [systolic and diastolic] and body weight changes. The results showed that cyclofem and mesigyna are highly effective contraceptives that caused side effects in less than 10% of users and were acceptable to women as evidenced by a high continuation rate over the study period
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Progesterone
Limits:
Female
/
Humans
Language:
English
Journal:
Bull. Alex. Fac. Med.
Year:
1993
Similar
MEDLINE
...
LILACS
LIS